Page last updated: 2024-10-30

mebendazole and Hepatitis B

mebendazole has been researched along with Hepatitis B in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, J1
Fu, LL1
Tian, M1
Liu, HQ1
Li, JJ1
Li, Y1
He, J1
Huang, J1
Ouyang, L1
Gao, HY1
Wang, JH1

Other Studies

1 other study available for mebendazole and Hepatitis B

ArticleYear
Design and synthesis of a novel candidate compound NTI-007 targeting sodium taurocholate cotransporting polypeptide [NTCP]-APOA1-HBx-Beclin1-mediated autophagic pathway in HBV therapy.
    Bioorganic & medicinal chemistry, 2015, Mar-01, Volume: 23, Issue:5

    Topics: Antiviral Agents; Apolipoproteins B; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Cell Line,

2015